Rbf Capital, LLC Concert Pharmaceuticals, Inc. Transaction History

Rbf Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.34 - $5.84 $68,489 - $92,161	-15,781 Reduced 24.31%	49,122 $286,000
Q3 2022 Nov 14, 2022	SELL	$4.27 - $7.2 $26,465 - $44,625	-6,198 Reduced 8.72%	64,903 $435,000
Q1 2022 May 16, 2022	SELL	$2.73 - $3.94 $9,615 - $13,876	-3,522 Reduced 4.72%	71,101 $262,000
Q4 2021 Feb 14, 2022	SELL	$2.69 - $4.22 $169,155 - $265,366	-62,883 Reduced 45.73%	74,623 $235,000
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.15 $5,072 - $6,640	-1,600 Reduced 1.15%	137,506 $450,000
Q2 2021 Aug 16, 2021	BUY	$3.77 - $5.24 $524,429 - $728,915	139,106 New	139,106 $587,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Rbf Capital, LLC with notifications on news.